Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

10 Years of Hope
Celebrate with us!

Open Medicine Foundation is turning ten years old! Please join us in celebrating a decade of leading research and delivering hope.

A Cure Is Out There

People with Chronic Complex Diseases deserve the right to live full, productive lives.

Scientific
Advisory Board
Scientific
Advisory Board
Scientific
Advisory Board
An Alliance of
Brilliant Scientific Minds

19 World-renowned scientists

2 Nobel Laureates

6 National Academy of Sciences Members

World-Class Research

6 OMF established ME / CFS Collaborative Research Centers

Final MERC

OMF Supported

Medical Education Resource Center (MERC)
at Bateman Horne Center

An initiative to increase access to knowledgeable healthcare providers and improve patient care for those with multi-system Chronic Complex Diseases (msCCD).

OMF Awarded Score of 100
on Charity Navigator!

OMF’s score of 100 serves as an indicator of trust, demonstrating our longstanding commitment to ensuring accountability, transparency, and measures of financial health, including stability, efficiency and sustainability.

previous arrowprevious arrow
next arrownext arrow

OMF ACCELERATES RESEARCH ACROSS THE GLOBE

Since our inception in 2012, Open Medicine Foundation (OMF) has raised over $37 million to fund open and collaborative research and improve health care for millions suffering with multi-system chronic, complex diseases (msCCD). Our disease focus includes Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), Long COVID, Post-Treatment Lyme Disease, and Fibromyalgia.

We have facilitated and funded the establishment of 7 collaborative centers across the globe, in 4 countries and 3 continents. These centers are dedicated to diagnosing, treating, and ultimately curing these related chronic, complex diseases. 

Open Medicine Foundation is a US based global nonprofit, with an affiliate organization in Canada (OMF Canada) and a foreign branch in Australia (OMF Australia Ltd). Our 19 member Scientific Advisory Board is world renowned and includes two Nobel laureates and 6 National Academy of Sciences members.

OMF Supported Collaborative Centers

at Stanford

Ronald W. Davis, PhD
Director

Innovative, collaborative, multi-disciplinary research

Wenzhong Xiao, PhD
Co-Director

David Systrom, MD
Co-Director

Clinical and scientific mechanistic studies towards discovering new treatments

at Uppsala, Sweden

Jonas Bergquist, MD, PhD
Director

Research for biomarkers in body and brain

Chris Armstrong, PhD
Director

Precision research program

Wenzhong Xiao, PhD
Director

From data to disease mechanism and treatments

 

at Bateman Horne Center

Lucinda Bateman, MD
Medical Education Director

A global initiative to increase access to knowledgeable healthcare providers and improve patient care.

Long Covid TO ME/CFS RESEARCH PLAN

The current COVID-19 pandemic offers an unprecedented opportunity to understand how a viral infection may convert to ME/CFS in some patients.

The six Collaborative Research Centers have begun a unique,  extensive, in-depth longitudinal molecular study following COVID-19 patients. Their shared goal is to determine the pathways involved in maintaining long-term symptoms in some patients,  possibly converting to ME/CFS. They seek to learn about these pathways so as to develop biomarkers, novel drug targets,  new treatment, and prevention strategies.

OMF Scientific Advisory Board

19 world-renowned scientists

2 Nobel laureates

6 National Academy
of Sciences members

View our latest news

Condensed Precision Medicine Protocol for ME/CFS

The study aims to establish a condensed personalized research protocol that can be used to characterize ME/CFS in individual patients as it pertains to all their unique biological aspects, interacting with a complex chronic disease.

OMF Honors Severe ME Day 2022

August 8, 2022, marks Severe ME/CFS Day. On this day of recognition, Open Medicine Foundation shines a bright light on all those who live in darkness.

Nitrogen Hypothesis

This project aims to test the nitrogen hypothesis, which is that damaging, nitrogen-containing by-products of energy metabolism accumulate more readily in the cells of ME/CFS patients.

Join our Fight to Ignite ME / CFS Research
Across the Globe!

OMF’s international community —
United by a shared commitment to find answers to end ME / CFS and related multi-system chronic, complex diseases (msCCD).

The Faces of ME / CFS
What is ME / CFS?
Join OMF to Find A Cure

Take Action Now!

Please help us expand our research efforts across the globe. 
Every donation brings us closer to a fully funded research effort and the answers we all seek.

"Our donors want to stop millions from suffering and have come to expect research with impeccable credibility. The time is now to attract the kind of serious investment that will speed up our search for a cure and end these debilitating diseases."

Linda Tannenbaum, OMF Founder & CEO/President
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669